文献速递泌尿系结石

威斯康星结石生活质量问卷的验证与信度研究

Validation and Reliability of the Wisconsin Stone Quality of Life Questionnaire.
PubMed 文献 · J Urol · 2016-11-23

本研究在WISQOL开发中心(275例)及美国与加拿大8个地理分布不同的中心(1334例)共纳入1609例有肾结石病史的患者,评估WISQOL的外部效度与聚合效度及心理测量学特性。结果显示各条目反应选项变异性和内部一致性可接受,样本间评分差异少,域-总分相关系数均超过0.86,且能识别SF-36v2未发现的结石特异性健康相关生活质量下降。

要点

  • WISQOL内部一致性可接受,域-总分相关系数在两个样本中均超过0.86。
  • 有结石且伴结石相关症状的患者健康相关生活质量评分最低,无结石者评分更高。
  • 聚合效度子研究证实WISQOL能识别SF-36v2未发现的结石特异性生活质量下降。

核心结论

  • WISQOL内部一致,能区分不同结石状态和症状的患者,在北美人群中具有外部效度,可用于肾结石病的多中心健康相关生活质量研究。

研究设计与样本

  • 在WISQOL开发中心(开发样本)及美国与加拿大8个地理分布不同的中心(联盟样本)招募有肾结石病史的患者,共分析1609例,其中开发样本275例、联盟样本1334例。
  • 比较两样本的条目反应选项变异性、相关模式和内部一致性,并通过同时完成WISQOL和SF-36v2的患者评估聚合效度。

主要发现

  • 所有条目的反应选项变异性模式可接受,WISQOL内部一致性可接受。
  • 样本间评分比较显示差异很少,两个样本的域-总分WISQOL评分相关系数均超过0.86。
  • 条目水平分析显示变异适当,允许进行区分性评分。
  • 完成WISQOL时,有结石且伴结石相关症状的患者健康相关生活质量评分最低,有结石但无症状者和无结石者评分更高。
  • 聚合效度子研究证实WISQOL能识别SF-36v2未发现的结石特异性健康相关生活质量下降。

临床怎么用

  • WISQOL可用于肾结石病的多中心健康相关生活质量研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: WISQOL (Wisconsin Stone Quality of Life questionnaire) is a disease specific, health related quality of life measure designed for patients who form kidney stones. The purpose of this study was to demonstrate the external and convergent validity of WISQOL and assess its psychometric properties. MATERIALS AND METHODS: At the WISQOL creation site (development sample) and at 8 geographically diverse centers in the United States and Canada (consortium sample) patients with a history of kidney stones were recruited. Item response option variability, correlation patterns and internal consistency were compared between samples. Convergent validity was assessed by patients who completed both WISQOL and SF-36v2® (36-Item Short Form Health Survey, version 2). RESULTS: Results were analyzed in 1,609 patients, including 275 in the development sample and 1,334 in the consortium sample. Response option variability patterns of all items were acceptable. Internal WISQOL consistency was acceptable. Intersample score comparisons revealed few differences. For both samples the domain-total WISQOL score correlations exceeded 0.86. Item level analyses demonstrated suitable variation, allowing for discriminatory scoring. At the time that they completed WISQOL, patients with stones and stone related symptoms scored lowest for health related quality of life. Patients with stones but no symptoms and those with no stones scored higher. The convergent validity substudy confirmed the ability of WISQOL to identify stone specific decrements in health related quality of life that were not identified on SF-36v2. CONCLUSIONS: WISQOL is internally consistent and discriminates among patients with different stone statuses and symptoms. WISQOL is externally valid across the North American population. It may be used for multicenter health related quality of life studies in kidney stone disease.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Penniston KL, Antonelli JA, Viprakasit DP, et al. Validation and Reliability of the Wisconsin Stone Quality of Life Questionnaire. J Urol. 2016. PMID: 27889419. doi:10.1016/j.juro.2016.11.097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。